Moving gemcitabine/nab-paclitaxel to every-other-week dosing decreases infusion visits and may lessen cumulative toxicity, ...
SurvivorNet on MSN
Could timing give your cancer treatment a boost? New study on the best time to receive immunotherapy & chemo for non-small cell lung cancer
A new randomized clinical trial showed that receiving immunochemotherapy infusions earlier in the day may help patients with ...
Pancreatic cancer treatment relies on surgery, chemotherapy, and radiation, with surgery for non-metastatic, technically resectable tumors. Advances in chemotherapy, neoadjuvant approaches, and ...
Chemotherapy uses medicines to kill fast-growing cells (like cancer cells) or to keep them from dividing (which is how cancers grow). It is a systemic treatment. This means the medicines will travel ...
Overcoming tumor resistance to chemotherapy drugs has long been a challenge for oncology clinicians and researchers. Now, a new study suggests that blocking a key protein, p300, may force damaged ...
SurvivorNet on MSN
More control, better quality of life: What to know about tarlatamab, the new immunotherapy drug approved for small-cell lung cancer
Tarlatamab (Imdelltra) is a new type of immunotherapy approved for people with small-cell lung cancer whose disease has ...
DOCTOR, SEVERAL NEW TREATMENTS ARE REVOLUTIONIZING THE FIGHT AGAINST BREAST CANCER AND CHIEF OF MEDICAL ONCOLOGY AT MERCY MEDICAL CENTER, DOCTOR DAVID REISBERG IS JOINING US NOW WITH SOME MORE ...
New cancer research pioneered by Memorial Sloan Kettering points to a strong alternative to chemotherapy, surgery and radiation for some forms of cancer. Nearly 80% of patients who suffered from a ...
Good news for a grave concern. Researchers believe a groundbreaking new drug can offer hope to those diagnosed with this deadly breast cancer, creating a new standard of care and improved survival ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results